833
Views
20
CrossRef citations to date
0
Altmetric
Original Article

No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis

, , , &
Pages 274-280 | Received 15 Jun 2015, Accepted 02 Oct 2015, Published online: 15 Nov 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rob G. H. Driessen, Rald V. M. Groven, Johan van Koll, Guy J. Oudhuis, Dirk Posthouwer, Iwan C. C. van der Horst, Dennis C. J. J. Bergmans & Ronny M. Schnabel. (2021) Appropriateness of empirical antibiotic therapy and added value of adjunctive gentamicin in patients with septic shock: a prospective cohort study in the ICU. Infectious Diseases 53:11, pages 830-838.
Read now

Articles from other publishers (19)

Qonita Kurnia Anjani, Akmal Hidayat Bin Sabri, Aaron J. Hutton, Álvaro Cárcamo-Martínez, Luki Ahmadi Hari Wardoyo, Alvanov Zpalanzani Mansoor & Ryan F. Donnelly. (2023) Microarray patches for managing infections at a global scale. Journal of Controlled Release 359, pages 97-115.
Crossref
Chu-Lin Chou, Nai-Chen Chuang, Hui-Wen Chiu, Chia-Te Liao, Yung-Ho Hsu & Tzu-Hao Chang. (2022) Aminoglycosides use has a risk of acute kidney injury in patients without prior chronic kidney disease. Scientific Reports 12:1.
Crossref
Caspar J. Hodiamont, Annemieke K. van den Broek, Suzanne L. de Vroom, Jan M. Prins, Ron A. A. Mathôt & Reinier M. van Hest. (2022) Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review. Clinical Pharmacokinetics 61:8, pages 1075-1094.
Crossref
Gretchen L. Sacha, Pavithra Srinivas, Simon W. Lam & Stephanie N. Bass. (2022) Comparison of Single-Dose and Extended-Duration Empiric Aminoglycoside Combination Therapy in Patients With Septic Shock. American Journal of Therapeutics 29:2, pages e163-e174.
Crossref
M. Cobussen, M.B. Haeseker, J. Stoffers, V.H.M. Wanrooij, P.H.M. Savelkoul & P.M. Stassen. (2021) Renal safety of a single dose of gentamicin in patients with sepsis in the emergency department. Clinical Microbiology and Infection 27:5, pages 717-723.
Crossref
J.W. Timotëus Deelen, W.C. Rottier, A.G.M. Buiting, J.W. Dorigo-Zetsma, J.A.J.W. Kluytmans, P.D. van der Linden, S.F.T. Thijsen, B.J.M. Vlaminckx, A.J.L. Weersink, H.S.M. Ammerlaan, M.J.M. Bonten & C.H. van Werkhoven. (2021) Short-course aminoglycosides as adjunctive empirical therapy in patients with Gram-negative bloodstream infection, a cohort study. Clinical Microbiology and Infection 27:2, pages 269-275.
Crossref
Lucie Benetazzo, Pierre-Yves Delannoy, Marion Houard, Frederic Wallet, Fabien Lambiotte, Anne Vachée, Christian Batt, Nicolas Van Grunderbeeck, Saad Nseir, Olivier Robineau & Agnès Meybeck. (2020) Combination Therapy with Aminoglycoside in Bacteremiasdue to ESBL-Producing Enterobacteriaceae in ICU. Antibiotics 9:11, pages 777.
Crossref
Karolina Liljedahl Prytz, Mårten Prag, Hans Fredlund, Anders Magnuson, Martin Sundqvist & Jan Källman. (2020) Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis. PLOS ONE 15:7, pages e0236864.
Crossref
P.J. Lillie, G. Johnson, M. Ivan, G.D. Barlow & P.J. Moss. (2019) Escherichia coli bloodstream infection outcomes and preventability: a six-month prospective observational study. Journal of Hospital Infection 103:2, pages 128-133.
Crossref
Akmal H. Sabri, Jane Ogilvie, Khuriah Abdulhamid, Volha Shpadaruk, John McKenna, Joel Segal, David J. Scurr & Maria Marlow. (2019) Expanding the applications of microneedles in dermatology. European Journal of Pharmaceutics and Biopharmaceutics 140, pages 121-140.
Crossref
Nicole Le Saux & Joan Robinson. (2019) Aminoglycosides—alive and well in treatment of pediatric infections: A case of benefit versus risk. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 4:1, pages 1-5.
Crossref
Maarten Cobussen, Patricia M. Stassen, Dirk Posthouwer, Frank H. van Tiel, Paul H. M. Savelkoul, Thomas Havenith & Michiel B. Haeseker. (2019) Improving peak concentrations of a single dose regime of gentamicin in patients with sepsis in the emergency department. PLOS ONE 14:1, pages e0210012.
Crossref
Sarah Carlsen, Jonas Boel, Jens Otto Jarløv, Ida Gjørup, Christian Søborg & Magnus Arpi. (2018) The effect of short-course gentamicin therapy on kidney function in patients with bacteraemia—a retrospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases 37:12, pages 2307-2312.
Crossref
Aurélie Lavergne, Cécile Vigneau, Elisabeth Polard, Louise Triquet, Nathalie Rioux-Leclercq, Pierre Tattevin & Léonard Golbin. (2018) Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature review. International Journal of Antimicrobial Agents 52:3, pages 344-349.
Crossref
Clare Morlidge, Catherine Berresford, Andrew Findlay, Rahul Bandopadhyay & Suresh Mathavakkannan. (2018) Implications of single-dose gentamicin in acute kidney injury. Journal of Kidney Care 3:4, pages 218-222.
Crossref
Rachel S. Hayward, Jan Harding, Rob Molloy, Lucy Land, Kate Longcroft-Neal, David Moore & Jonathan D. C. Ross. (2018) Adverse effects of a single dose of gentamicin in adults: a systematic review. British Journal of Clinical Pharmacology 84:2, pages 223-238.
Crossref
Donghua Xie, Victor Gheiler, Isabel Lopez, Guy M. NehrenzSr.Sr., Boris Klopukh, Fernando Bianco, Paul Perito & Edward Gheiler. (2017) Experience With Prophylactic Gentamicin During Penile Prosthesis Surgery: A Retrospective Comparison of Two Different Doses. The Journal of Sexual Medicine 14:9, pages 1160-1164.
Crossref
Or Goren & Idit Matot. (2016) Update on perioperative acute kidney injury. Current Opinion in Critical Care 22:4, pages 370-378.
Crossref
Saira B. Chaudhry. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 229 241 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.